Impact ledger
NeoGenomics, Inc. (NEO)
7 events mapped to this ticker since 2026-06-16.
Assumption changes
| Date | Assumption | Direction | Magnitude | Conf. |
|---|---|---|---|---|
| 2026-06-17 | share_count | Bearish | — | 0.70 |
| 2026-06-17 | net_debt | Bearish | — | 0.70 |
| 2026-06-17 | interest_expense | Bearish | — | 0.70 |
| 2026-06-16 | interest_expense | Bullish | — | 0.70 |
| 2026-06-16 | dilution | Bullish | — | 0.70 |
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-06-25 | Event | Governance improvement, strategic direction, and potential for enhanced oversight. Carolyn Starrett's experience in healthcare and technology could influence strategic decisions. | watch | 3-12m | 0.30 |
| 2026-06-22 | Event | Direct financing activity, potential future dilution, and interest expense management. | mixed | 1-5y | 0.70 |
| 2026-06-17 | Event | Share repurchases reduce the number of outstanding shares, increasing EPS and potentially signaling management's confidence in the company's valuation. The use of convertible note proceeds for buybacks suggests a strategic capital structure decision. | Bullish | 1-3m | 0.70 |
| 2026-06-17 | Event | Debt reduction and potential interest expense savings. The repurchase at a discount suggests a favorable transaction for the company, reducing future liabilities and potentially improving credit metrics. | Bullish | 1-3m | 0.70 |
| 2026-06-17 | Event | Capital structure change, potential dilution, and reduced interest expense. | mixed | 1-3m | 0.70 |
| 2026-06-17 | Event | Capital structure changes, potential for dilution, and financing cost implications. | mixed | 1-3m | 0.70 |
| 2026-06-16 | Event | Capital structure optimization, debt refinancing, potential share dilution/buyback | mixed | 1-3m | 0.70 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for NEO, start a trial or view the NEO entity page.